Risk Management



Giant Cell Arteritis Toolkit (2022)

Allegations of failure to diagnose are common in medical malpractice lawsuits against ophthalmologists. Some ophthalmic conditions, such as giant cell arteritis (GCA), have a short window for diagnosis and treatment. The patient then risks severe bilateral vision loss, and the treating ophthalmologist incurs liability exposure.

OMIC offers the following tools, developed by board member Ron Pelton, MD, to help ophthalmologists strengthen their diagnostic and patient management process for GCA:

Giant Cell Arteritis Checklist

·         Helps prompt questions to ask patients during the work-up, and track completion of key tests and consults.

GCA Pt Info Sheet with Consent-Refusal

·         Supports communication to patients of signs and symptoms to watch for and instructions for contacting the ophthalmologist. Includes a sample form to document the patient’s understanding of GCA in general and consent or refusal to proceed with treatment in general. 

 

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.

61864684